Intellectual Property and Biotechnology: The U.S. Internal Experience--Part I
, In the development of biotechnology in the United States, many questions were raised about the appropriateness of applying to this area a traditional robust system of intellectual property rights. Despite these hesitations, the U.S. rejected suggested modifications. This was a mistake, and there i...
Main Author: | |
---|---|
Format: | Electronic Article |
Language: | English |
Check availability: | HBZ Gateway |
Journals Online & Print: | |
Fernleihe: | Fernleihe für die Fachinformationsdienste |
Published: |
Johns Hopkins Univ. Press
2006
|
In: |
Kennedy Institute of Ethics journal
Year: 2006, Volume: 16, Issue: 1, Pages: 1-37 |
Online Access: |
Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |
Summary: | , In the development of biotechnology in the United States, many questions were raised about the appropriateness of applying to this area a traditional robust system of intellectual property rights. Despite these hesitations, the U.S. rejected suggested modifications. This was a mistake, and there is a need to develop a modified system that promotes more of the relevant ethical values. |
---|---|
ISSN: | 1086-3249 |
Contains: | Enthalten in: Kennedy Institute of Ethics, Kennedy Institute of Ethics journal
|
Persistent identifiers: | DOI: 10.1353/ken.2006.0002 |